Application for quotation of +securities

Announcement Summary

For personal use only

Entity name

IMRICOR MEDICAL SYSTEMS INC.

Announcement Type

New announcement

Date of this announcement

Thursday February 24, 2022

The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

Total number of +securities to be quoted

ASX +security

Number of +securities to

code

Security description

be quoted

Issue date

IMR

CDI 1:1 US PERSON PROHIBITED EXCLUDING

59,300

09/02/2022

QIB

Refer to next page for full details of the announcement

Application for quotation of +securities

1 / 6

Application for quotation of +securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

IMRICOR MEDICAL SYSTEMS INC.

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2

Registered number type

Registration number

ARBN

633106019

1.3

ASX issuer code

IMR

  1. The announcement is New announcement
  2. Date of this announcement

24/2/2022

Application for quotation of +securities

2 / 6

Application for quotation of +securities

Part 2 - Type of Issue

For personal use only

2.1 The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

2.2 The +securities to be quoted are:

Additional +securities in a class that is already quoted on ASX ("existing class")

Application for quotation of +securities

3 / 6

Application for quotation of +securities

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Existing +securities converting into additional +securities in an existing class

FROM (Existing Class)

ASX +security code and description

IMRAJ : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

TO (Existing Class)

ASX +security code and description

IMR : CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB

Please state the number of options

The first date the options were

that were exercised or other

exercised or other +convertible

+convertible securities that were

securities were converted

converted

28/1/2022

59,300

The last date the options were exercised or other +convertible securities were converted

28/1/2022

For personal use only

Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)?

No

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by:

An issue of new +securities

The underlying securities being received by the holder are:

Intended to be, but are not yet, quoted by ASX

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme?

Yes

Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate?

No

Issue date

9/2/2022

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class?

Yes

Application for quotation of +securities

4 / 6

Application for quotation of +securities

Issue details

For personal use only

Number of +securities to be quoted

59,300

Are the +securities being issued for a cash consideration?

Yes

In what currency is the cash consideration being paid? What is the issue price per +security?

USD - US Dollar

USD 0.52000000

Any other information the entity wishes to provide about the +securities to be quoted

Application for quotation of +securities

5 / 6

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Imricor Medical Systems Inc. published this content on 24 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 February 2022 06:21:08 UTC.